Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference
BETHESDA, Md., March 09, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company...
Month: March 2023
Intercept Pharmaceuticals to Conduct One-on-One Meetings with Investors at the Barclays Global Healthcare Conference March 14, 2023
MORRISTOWN, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development...
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
LAKEWOOD, Colo., March 09, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results...
Hydreight Technologies Inc. Announces DTC Eligibility
VANCOUVER, British Columbia and LAS VEGAS, March 09, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV:NURS) (FSE: SO6) (OTCQB: HYDTF)...
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-- Announced preclinical data providing further proof-of-concept for Prime Editing’s ability to achieve restoration of genetic function, as well as...
Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023
ATLANTA, March 09, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide...
Arcutis to Present New Topical Roflumilast Data Including Late Breaking Atopic Dermatitis Pivotal Trial Data During the American Academy of Dermatology (AAD) Annual Meeting
Late breaking session to highlight new data from the INTEGUMENT Phase 3 trials evaluating roflumilast cream in atopic dermatitisNew national...
Novel Target-Specific Nanoparticles for Diagnosis and Treatment of Pancreatic Cancer
By Dr. Jill Smith Pancreatic cancer is well known as one of the deadliest cancers, with a paltry 11% survival...
Molecure announces first patient dosed in Phase I trial with novel, first-in-class dual arginase inhibitor OATD-02 for the treatment of cancer
Marcin Szumowski Chief Executive Officer Samson Fung Chief Medical Officer OATD-02 First-in-class dual arginase inhibitorMolecure announces first patient dosed in...
Smile Health Orthodontics (SHO) Now Offering Patients 3D Printed Clear Aligners & 3D Printed LightForce Ceramic Braces
Patients can safely and comfortably accelerate their treatment compared to traditional metal braces A 3D printed model fresh out of...
Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th
CHARLOTTESVILLE, Va., March 08, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage...
Novan Moves Forward with Unified Corporate Branding
– Novan is a fully integrated pharmaceutical company with proven capabilities across drug development through to commercialization – – EPI...
Capricor Therapeutics to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on March 15
-Company to Host Conference Call, March 15, 2023, at 4:30 p.m. ET-SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Capricor...
Editas Medicine Strengthens Executive Leadership Team with Appointment of Linea Aspesi as Chief People Officer
Linea Aspesi Linea Aspesi, Executive Vice President and Chief People Officer, Editas MedicineCAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) --...
AIM ImmunoTech Announces Publication of New Analysis of the Mechanism of Action of Ampligen as a Potential Prophylactic Therapy Against Ebola Virus Disease
OCALA, Fla., March 08, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma...
Ceapro Announces Data from Research Collaboration with the Angiogenesis Foundation to be Presented at the 2023 Annual Meeting of the Wound Healing American Society
– Oral presentation to highlight unique results from pre-clinical studies characterizing the in vivo bioactivity of Ceapro’s oat-derived bioactive products...
Caira Surgical Unveils Caira TKA Radar Navigation System During CG 2023 Musculoskeletal Conference
Company raising $10M in Series A Funding to bring its advanced radar surgical tracking and fast landmark registration technologies to...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2022 Financial Results and Host a Conference Call on Tuesday, March 14, 2023
WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...
Intelligent Bio Solutions Inc. Announces Pricing of $2.2 Million Public Offering
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company...
Sofwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
- Record Quarterly Revenue of $13.8M - Full Year Revenue Grew 63% YoY to $35.6M - Over 50,000 Pulse Treatments Conducted in...